- Home
- AIXC vs ICU Comparison
AIXC vs ICU Comparison
Compare AIXC & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIXC | ICU |
|---|---|---|
| Founded | 1996 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 19.1M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AIXC | ICU |
|---|---|---|
| Price | $0.70 | $3.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 33.1K | ★ 72.1K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,983,556.00 | $1,234,000.00 |
| Revenue This Year | N/A | $53.00 |
| Revenue Next Year | N/A | $50.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 814.07 |
| 52 Week Low | $0.59 | $0.22 |
| 52 Week High | $2.98 | $5.38 |
Technical Indicators
Market Signals| Indicator | AIXC | ICU |
|---|---|---|
| Relative Strength Index (RSI) | 37.15 | 40.53 |
| Support Level | $0.65 | $2.26 |
| Resistance Level | $1.45 | $4.96 |
| Average True Range (ATR) | 0.10 | 0.27 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 34.06 | 24.16 |
Price Performance
Historical ComparisonAbout AIXC AIxCrypto Holdings Inc.
AIxCrypto Holdings Inc is a technology infrastructure company focused on the convergence of artificial intelligence and blockchain-based programmable systems. The Company develops software platforms and programmable infrastructure designed to facilitate the tokenization of real-world assets (RWA) and the deployment of Embodied Artificial Intelligence (EAI) in commercial environments. Its mission is to serve as the regulated, programmable infrastructure layer connecting traditional capital markets with on-chain systems and AI-enabled commercial systems.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.